F449-1803 Screening compound: 2-{[5-(tert-butylamino)-6-(3-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl](methyl)amino}-N-cycloheptylacetamide

F449-1803 Screening compound: 2-{[5-(tert-butylamino)-6-(3-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl](methyl)amino}-N-cycloheptylacetamide
F449-1803 Screening compound: 2-{[5-(tert-butylamino)-6-(3-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl](methyl)amino}-N-cycloheptylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F449-1803
2-{[5-(tert-butylamino)-6-(3-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl](methyl)amino}-N-cycloheptylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F449-1803

Molecular Formula

C25H36N6OS (C25 H36 N6 OS)

Compound Name

2-{[5-(tert-butylamino)-6-(3-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl](methyl)amino}-N-cycloheptylacetamide

IUPAC name

2-{[5-(tert-butylamino)-6-(3-methylphenyl)imidazo[21-b][134]thiadiazol-2-yl](methyl)amino}-N-cycloheptylacetamide

SMILES

CC(C)(C)Nc1c(-c2cc(C)ccc2)nc2sc(N(C)CC(NC3CCCCCC3)=O)nn12

InChI

InChI=1S/C25H36N6OS/c1-17-11-10-12-18(15-17)21-22(28-25(2,3)4)31-23(27-21)33-24(29-31)30(5)16-20(32)26-19-13-8-6-7-9-14-19/h10-12,15,19,28H,6-9,13-14,16H2,1-5H3,(H,26,32)

InChI Key

CPMDBTXAUXZKEU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27129688

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.67

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.770

Distribution Coefficient, logD

5.770

Water Solubility, LogSw

-5.31

Polar Surface Area

57.810

Acid Dissociation Constant (pKa)

14.90

Base Dissociation Constant (pKb)

3.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.00

F449-1803 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F449-1803 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F449-1803?
Check Price and Availability of F449-1803, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F449-1803 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F449-1803
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F449-1803
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F449-1803 available by request